UAG's U.S. Federal Loan Program Eligibility is Reinstated - KCBD NewsChannel 11 Lubbock

UAG's U.S. Federal Loan Program Eligibility is Reinstated

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE Universidad Autónoma de Guadalajara

WASHINGTON, Feb. 26, 2014 /PRNewswire-USNewswire/ -- The United States Department of Education (USDOE) ruled to reinstate U.S. federal loan program eligibility to the Universidad Autónoma de Guadalajara (UAG) Medical School in Jalisco, Mexico.  Following a USDOE regulatory change, federal financial aid for over 1,200 UAG students from the United States, including Puerto Rico, was briefly suspended pending a review of UAG clinical programs in the continental United States and Puerto Rico.  University officials wish to express their gratitude to the USDOE and to the students for their patience and resolve over the last several weeks, and to highlight the incredible support they received from alumni, friends, and supporters around the globe.  As of yesterday, all affected students will have their government-supported financial aid restored.  The UAG welcomes several hundred students from the continental U.S. and Puerto Rico annually and has been eligible for the United States federal loan programs since 1982.  The University is pleased to continue a long tradition of educating U.S. citizens from the continental U.S. and Puerto Rico, and to contribute to the pledge U.S. President Obama and Mexican President Peña Nieto made to increased bilateral student exchange as part of the U.S. State Department's 100,000 Strong in the Americas.

©2012 PR Newswire. All Rights Reserved.

Powered by WorldNow

5600 Avenue A
Lubbock, TX. 79404

FCC Public File
publicfile@kcbd.com
806-744-1414
EEO Report
Closed Captioning

All content © Copyright 2000 - 2014 Worldnow and KCBD. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.